OrthoSensor has raised $2.5 million in a new round of financing, according to a filing with the Securities and Exchange Commission.
In the round, the Dania Beach, Fla.-based company offered debt, options, warrants and securities to be acquired upon the exercising of those options or warrants, according to the filing. The sale was recorded on Aug. 10 of this year, with one investor. The company did not reveal how it would use the money.
OrthoSensor recently won FDA 510(k) clearance for its Verasense sensor-assisted device designed to be used with Zimmer Biomet‘s (NYSE:ZBH) Persona knee system during total knee replacement procedures.
Data from a prospective multi-center study of the Verasense showed the system was able to reduce post-operative pain, accelerate patient activity levels, improve functional outcomes and increase patient satisfaction scores. Results indicated that 98% of patients whose knees were balanced using Verasense saying they were satisfied to very satisfied with the procedures at three years post-operation, the company said.